Manufacturer record
Trugen Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Trugen Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2020 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
11 records linked to Trugen Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atenolol Tablets IP 50 MG, | TT 251884Mfg 2025-11 · Exp 2027-10 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Diclofenac Sodium and Paracetamol Tablets IP | TT240758Mfg 2024-06 · Exp 2026-05 | Dissolution Of ParacetamolDissolution | Government of NCT of DelhiState lab | Sep 2025 |
| Telmisartan Tablets IP 40 mg (Telwin-40 Tablets) | TT230416Mfg 2023-03 · Exp 2025-02 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Glimepiride Tablets IP 1 mg | T22051Mfg 2022-02 · Exp 2024-01 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Feb 2023 |
| Glimepiride Tablets IP 1 mg | T22060Mfg 2022-03 · Exp 2024-02 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Feb 2023 |
| Enalapril Maleate Tablets I.P. 5 mg | T22093Mfg 2022-05 · Exp 2024-04 | Dissolution and AssayAssay | CDL KolkataCDSCO lab | Oct 2022 |
| Pregabalin Capsules IP 75 mg | T21003Mfg 2021-01 · Exp 2022-12 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2021 |
| Pregabalin Capsules IP 75 mg | T20056Mfg 2020-05 · Exp 2022-04 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2021 |
| Glimepiride Tablets IP 1 mg | T20053Mfg 2020-05 · Exp 2022-04 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2021 |
| Folic Acid Tablets IP 5 mg | T20072Mfg 2020-07 · Exp 2022-06 | Description & Hydrolysis ProductsDescription | CDL KolkataCDSCO lab | Jul 2021 |
| Olmemark-40 (Olmesartan Medoxomil Tablet IP 40 mg) | TPT8689Mfg 2018-06 · Exp 2020-05 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.